RGEN
Repligen Corporation (RGEN)
Last Price$155.4(2.4%)
Market Cap$8,979.7M
Last Earnings date
Sep'24
Q3 2024
$0.32
4.6% miss
Next quarter EPS Estimate
$0.41
24.2%YoY

RGEN Earnings and Expectations

Revenue

Crunching data... Almost there!

RGEN EPS (Earnings Per Share)

Crunching data... Almost there!

RGEN Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$50.0M$100.0M$150.0M$200.0MJan'20Apr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24$69.5M$87.5M$108.6M$163.0M$186.5M$207.6M$186.8M$159.2M$155.7M$154.1M
Value Sense
Actual Revenue
Forecast Revenue

RGEN Earnings History

Dec'14Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24
Revenue actual$16.4M$20.8M$21.5M$19.8M$21.4M$25.1M$29.2M$24.7M$25.6M$30.6M$32.5M$36.6M$41.6M$44.8M$47.7M$49.5M$51.9M$60.6M$70.7M$69.4M$69.5M$76.1M$87.5M$94.1M$108.6M$142.8M$163.0M$178.2M$186.5M$206.4M$207.6M$200.7M$186.8M$182.7M$159.2M$141.2M$155.7M$151.3M$154.1M$154.9M
Revenue estimate$11.3M$16.2M$16.2M$16.2M$16.2M$20.9M$20.9M$20.9M$20.9M$26.5M$26.5M$26.5M$26.5M$39.6M$39.6M$39.6M$39.6M$53.5M$64.1M$66.1M$68.4M$71.6M$78.4M$86.4M$93.9M$117.0M$144.2M$163.9M$179.3M$185.5M$189.1M$191.5M$184.6M$181.4M$165.9M$140.7M$155.4M$150.1M$154.1M$153.0M
Revenue surprise45.0%28.6%32.5%22.4%32.5%20.0%39.5%18.0%22.4%15.4%22.4%38.0%57.0%13.3%20.7%25.2%31.3%13.3%10.4%5.1%1.6%6.2%11.6%8.8%15.7%22.1%13.0%8.7%4.0%11.3%9.8%4.8%1.2%0.7%4.1%0.4%0.2%0.9%0.0%1.2%
EPS actual($0.01)$0.09$0.11$0.08$0.01$0.05$0.12$0.03$0.15$0.09$0.25$0.11$0.28$0.08$0.06$0.11$0.13$0.18$0.17$0.03$0.07$0.19$0.30$0.28$0.37$0.54$0.66$0.61$0.53$0.81$0.90$0.73$0.88$0.52$0.36$0.33($0.46)$0.04$0.06$0.32
EPS estimate$0.05$0.05$0.05$0.05$0.05$0.08$0.08$0.08$0.08$0.11$0.11$0.11$0.11$0.13$0.13$0.13$0.13$0.21$0.25$0.19$0.18$0.22$0.28$0.28$0.31$0.42$0.52$0.64$0.65$0.72$0.71$0.68$0.58$0.59$0.48$0.16$0.33$0.30$0.33$0.34
EPS surprise124.4%80.0%120.0%60.0%80.0%37.5%50.0%62.5%87.5%18.2%127.3%0.0%154.5%38.5%53.8%15.4%0.0%13.1%32.0%84.4%62.0%14.1%8.0%1.4%20.8%27.8%26.0%4.2%18.3%12.5%26.1%7.4%52.6%11.6%24.2%100.2%241.2%86.7%81.8%4.6%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$154.9M 9.7% YoY
$77.5M 112.0% YoY
50.0% margin
Cost of revenue
$77.4M (26.0%) YoY
Operating expenses
$85.3M 29.2% YoY
Net income
$654.0K 0.0% YoY
(0.4%) margin
Other: $2,656.0K
R&D
$9,710.0K (8.2%) YoY
6.3% of revenue
SG&A
$72.3M 30.4% YoY
46.7% of revenue

Competing with RGEN Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$8,979.7M
$616.0M
($0.04)
9.7%
(3.0%)
Beat by 0.5%
Miss by 1.9%
8.2%
29.0%
Beats: 6
Misses: 4
0.3%
140.7%
$207.3B
$8,352.1M
$8.46
25.2%
123.8%
Beat by 7.8%
Beat by 117.1%
(8.7%)
(53.6%)
Beats: 8
Misses: 2
14.2%
20.5%
$66.3B
$20.6B
$6.03
9.8%
8.2%
Beat by 1.2%
Miss by 64.8%
5.5%
228.9%
Beats: 8
Misses: 2
9.0%
145.1%
$46.6B
$9,926.1M
$1.48
0.9%
(100.0%)
Beat by 2.8%
Miss by 100.0%
1.1%
0.0%
Beats: 8
Misses: 2
2.8%
50.8%
$34.6B
$4,926.8M
$4.03
10.3%
N/A
Beat by 1.1%
Miss by 191.3%
1.3%
(213.5%)
Beats: 7
Misses: 3
9.2%
35.4%
$18.6B
$3,895.4M
$1.97
9.8%
34.9%
Beat by 2.1%
Miss by 36.3%
(3.9%)
57.8%
Beats: 6
Misses: 4
5.8%
102.2%
$17.9B
$12.9B
($1.28)
(29.1%)
N/A
undefinedN/A
undefinedN/A
(4.6%)
(150.5%)
Beats: 6
Misses: 4
148.7%
N/A
$16.9B
$2,893.1M
$6.74
2.3%
(3.8%)
Beat by 1.2%
Beat by 3.5%
(2.8%)
(6.1%)
Beats:
Misses:
5.3%
10.7%
$14.7B
$4,038.9M
$3.18
0.9%
(15.5%)
Beat by 4.5%
Miss by 14.1%
1.0%
19.0%
Beats: 8
Misses: 2
3.4%
27.1%
$10.4B
$2,094.4M
($5.68)
9.4%
N/A
Beat by 19.5%
Miss by 879.3%
(16.8%)
(115.8%)
Beats: 9
Misses: 1
1.9%
161.9%

FAQ

1. When was Repligen Corporation's last earnings date?

Repligen Corporation's last earnings date was Sep'24 (Q3 2024).

2. What is Repligen Corporation's EPS, and was there a surprise?

3. What is Repligen Corporation's revenue, and was there a surprise?

4. What is Repligen Corporation's next quarter EPS estimate?

Repligen Corporation's next quarter EPS estimate is $0.41, with an expected 24.2% YoY growth.